Insight Molecular Diagnostics (IMDX) Change in Accured Expenses (2015 - 2026)
Insight Molecular Diagnostics (IMDX) posted Change in Accured Expenses of -$105000.0 for Q1 2026, down 102.95% sequentially from $3.6 million in Q4 2025, and down 110.22% YoY from $1.0 million in Q1 2025.
Insight Molecular Diagnostics (IMDX) Change in Accured Expenses (2015 - 2026) Analysis & Trends
Insight Molecular Diagnostics (IMDX) has 12 years of Change in Accured Expenses data on file, last reported at -$105000.0 in Q1 2026.
- Quarterly Change in Accured Expenses fell 110.22% year-over-year to -$105000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.5 million (up 32.81% YoY) and the FY2025 annual result came in at $2.6 million, up 173.63% from the prior year.
- Change in Accured Expenses retreated to -$105000.0 in Q1 2026 per IMDX's latest filing, from $3.6 million in the prior quarter.
- The five-year high for Change in Accured Expenses was $3.6 million in Q4 2025, with the low at -$3.1 million in Q2 2025.
- Average Change in Accured Expenses over 5 years is -$56000.0, with a median of $126000.0 recorded in 2023.
- Year-over-year, Change in Accured Expenses plunged 12576.19% in 2023 and jumped 415.08% in 2024.
- Insight Molecular Diagnostics' Change in Accured Expenses stood at -$125000.0 in 2022, then slumped by 351.2% to -$564000.0 in 2023, then soared by 224.82% to $704000.0 in 2024, then surged by 404.97% to $3.6 million in 2025, then sank by 102.95% to -$105000.0 in 2026.
- Business Quant data shows IMDX's Change in Accured Expenses at -$105000.0 in Q1 2026, $3.6 million in Q4 2025, and $1.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 31,055.11 Bn | 31,054.65 Bn | 1.11 Bn | 235.00 Mn |
| 2 | Thermo Fisher Scientific | 191.02 Bn | 187.77 Bn | 7.74 Bn | - |
| 3 | Danaher | 137.16 Bn | 131.47 Bn | 3.59 Bn | -322.00 Mn |
| 4 | Idexx Laboratories | 42.82 Bn | 42.62 Bn | 722.74 Mn | - |
| 5 | Natera | 39.09 Bn | 37.99 Bn | 696.04 Mn | 98.23 Mn |
| 6 | Agilent Technologies | 37.61 Bn | 35.81 Bn | 990.00 Mn | - |
| 7 | Iqvia Holdings | 34.23 Bn | 32.25 Bn | 1.36 Bn | - |
| 8 | Illumina | 28.14 Bn | 26.98 Bn | 721.00 Mn | -47.00 Mn |
| 9 | Mettler Toledo International | 26.40 Bn | 26.33 Bn | 555.82 Mn | - |
| 10 | Insight Molecular Diagnostics | 196.41 Mn | 167.48 Mn | 15,000.00 | -105,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -105,000.00 |
| Mar 31, 2026 | -105,000.00 |
| Dec 31, 2025 | 3.56 Mn |
| Dec 31, 2025 | 3.56 Mn |
| Sep 30, 2025 | 1.18 Mn |
| Sep 30, 2025 | 1.18 Mn |
| Jun 30, 2025 | -3.11 Mn |
| Jun 30, 2025 | -3.11 Mn |
| Mar 31, 2025 | 1.03 Mn |
| Mar 31, 2025 | 1.03 Mn |
| Dec 31, 2024 | 704,000.00 |
| Dec 31, 2024 | 704,000.00 |
| Sep 30, 2024 | 649,000.00 |
| Sep 30, 2024 | 649,000.00 |
| Jun 30, 2024 | -1.24 Mn |
| Jun 30, 2024 | -1.24 Mn |
| Mar 31, 2024 | 854,000.00 |
| Mar 31, 2024 | 854,000.00 |
| Dec 31, 2023 | -564,000.00 |
| Dec 31, 2023 | -564,000.00 |